Nanotechnology Based Drug Delivery System Of Rivastigmine For The Treatment Of Alzheimer’s Disease. Journal of Pharmaceutical Negative Results [Internet]. 2022 Jan. 1 [cited 2026 Jun. 8];:2532-41. Available from: https://pnrjournal.com/index.php/home/article/view/9456